IDXX - CIK 0000874716
The table below shows IDEXX LABORATORIES INC /DE's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $200.53M | $208.17M | $164.59M | $163.97M | $308.64M | $401.59M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $603.54M | $566.88M | $560.56M | $527.46M | $511.25M | $533.61M |
| Inventory | $382.40M | $391.56M | $392.58M | $395.99M | $389.80M | $379.96M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.45B |
| $1.48B |
| $1.36B |
| $1.32B |
| $1.43B |
| $1.53B |
| Property, plant & equipment | $740.38M | $739.44M | $739.68M | $717.62M | $717.75M | $708.18M |
| Goodwill | $412.10M | $413.65M | $414.49M | $407.49M | $412.07M | $408.02M |
| Total assets | $3.39B | $3.39B | $3.33B | $3.21B | $3.35B | $3.41B |
| Accounts payable | $129.97M | $122.27M | $116.58M | $120.10M | $110.60M | $117.47M |
| Total current liabilities | $1.30B | $1.25B | $1.22B | $1.14B | $1.01B | $1.12B |
| Long-term debt | $299.85M | $374.82M | $449.81M | $449.80M | $524.76M | $524.74M |
| Total liabilities | $1.83B | $1.83B | $1.87B | $1.77B | $1.73B | $1.83B |
| Retained earnings | $6.67B | $6.14B | $5.87B | $5.58B | $5.12B | $4.88B |
| Total equity | $1.56B | $1.56B | $1.46B | $1.45B | $1.62B | $1.58B |